Personalis, Inc.
NASDAQ:PSNLMedical - Diagnostics & Research
+$0.34 today
- Market cap
- $1.62B
- Beta
- 2.28
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$0.92
Volume 1.47M
Average 2.31M
PSNL Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Personalis, Inc.NASDAQ: PSNL
Operating Margin · Q1 FY2026 · quarter ended Mar 2026
Operating margin narrows to -207.9%
Operating margin was -207.9% in Q1 FY2026, down 122.0 pp from a year earlier. On a trailing-twelve-month basis it was -158.9%, down 80.6 pp year over year.
Context
- Operating margin widened in 2 of the last 2 fiscal years.
- FY2024 was the highest level in the 3 fiscal years shown.
What to watch
Whether next quarter's operating margin reaches the consensus estimate of -168.9%, a -42.2 pp change from the same quarter last year.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -207.9%-62.2 pp QoQ
- Last fiscal yearDec 2025
- —— YoY
- LTMMar 2026
- -158.9%-80.6 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -122.0 pp | -42.2 pp | +79.8 pp |
| 1 year | — | — | — |
| 3 years | — | — | — |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2024
- -80.7%
- Year-over-year change
- +68.9pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | — | — |
| FY2024 | 2024-12-31 | -80.7% | +68.9pp |
| FY2023 | 2023-12-31 | -149.6% | +28.0pp |
| FY2022 | 2022-12-31 | -177.6% | -101.2pp |
| FY2021 | 2021-12-31 | -76.4% | — |
Operating Margin vs competitors
How PSNL compares with its peers on the latest reported figures
- PSNL's LTM Mar 2026 operating margin of -158.9% is the 9th highest of the 10 companies compared; the peer median is -13.3%.
- Its year-over-year change of -80.6 pp is the lowest of 10, against a peer median of +8.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 17.0% | +14.1 pp | +28.2 pp | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | 10.9% | +24.4 pp | — |
| LTM Jun 2026 | -8.6% | +8.1 pp | +21.8 pp | |
| LTM Jun 2026 | -10.7% | +4.2 pp | +52.5 pp | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | -13.3% | -14.8 pp | +281.7 pp |
| LTM Mar 2026 | -33.1% | -8.5 pp | -57.1 pp | |
| LTM Sep 2026 | -39.4% | +9.6 pp | +76.6 pp | |
| LTM Mar 2026 | -46.3% | -31.3 pp | +12.5 pp | |
| LTM Mar 2026 | -158.9% | -80.6 pp | — | |
| LTM Jun 2026 | -338.4% | +132.9 pp | +9435.2 pp | |
| Peer median (excluding PSNL) | -13.3% | +8.1 pp | +40.4 pp | |
Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 85.49M | 65.05M | 73.48M | 84.61M | 0 |
| Cost of Revenue | 53.84M | 51.7M | 55.27M | 57.79M | 53.87M |
| Gross Profit | 31.66M | 13.35M | 18.21M | 26.83M | (53.87M) |
| Gross Margin | 37.0% | 20.5% | 24.8% | 31.7% | — |
| Research & Development | 49.31M | 64.91M | 64.78M | 48.91M | 50.26M |
| Selling, General & Admin | 47.7M | 63.97M | 49.73M | 46.19M | 53.57M |
| Operating Expenses | 97.01M | 128.88M | 128.14M | 95.09M | 34.19M |
| Depreciation & Amortization | 6.01M | 8.43M | 11.3M | 10.94M | 10.05M |
| EBITDA | (59.01M) | (104.64M) | (96.81M) | (70.3M) | (71M) |
| EBITDA Margin | -69.0% | -160.9% | -131.7% | -83.1% | — |
| Operating Income | (65.35M) | (115.53M) | (109.94M) | (68.27M) | (88.06M) |
| Operating Margin | -76.4% | -177.6% | -149.6% | -80.7% | — |
| Interest Income | 367K | 2.4M | 5.9M | 5.51M | 7.16M |
| Interest Expense | 184K | 201K | 110K | 24K | 205K |
| Other Income / Expenses | 141K | 2.26M | 1.72M | (13M) | 6.81M |
| Income Before Tax | (65.21M) | (113.28M) | (108.21M) | (81.27M) | (81.25M) |
| Pre-Tax Margin | -76.3% | -174.1% | -147.3% | -96.0% | — |
| Income Tax Expense | 14K | 40K | 83K | 18K | 21K |
| Net Income | (65.23M) | (113.32M) | (108.3M) | (81.28M) | (81.27M) |
| Net Margin | -76.3% | -174.2% | -147.4% | -96.1% | — |
| EPS (Basic) | (1.49) | (2.48) | (2.25) | (1.37) | (0.91) |
| EPS (Diluted) | (1.49) | (2.48) | (2.25) | (1.37) | (0.91) |
| Weighted Avg Shares | 43.89M | 45.7M | 48.18M | 59.25M | 89.24M |
| Weighted Avg Shares (Diluted) | 43.89M | 45.7M | 48.18M | 59.25M | 89.24M |
Personalis, Inc.
NASDAQ:PSNL
Intrinsic Alpha fair value
Locked
Current Price
$14.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.